News

Published on 21 Mar 2023 on The Business Journals

Moderna CEO made $393M in stock sale last year, but pledges it to charity - Boston Business Journal


Article preview image

The CEO of Moderna Inc. cashed in on a $393 million stock option last year. He says he's donated the...

NASDAQ.VTNR price evolution
NASDAQ.MRNA price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Investing in Moderna (NASDAQ:MRNA) five years ago would have delivered you a 367% gain

For many, the main point of investing in the stock market is to achieve spectacular returns. Whil...

Simply Wall St. via Yahoo Finance 13 Apr 2024

Moderna director Noubar Afeyan sells over $1.6m in company stock By Investing.com

In a recent transaction, Noubar Afeyan, a director at Moderna , Inc. (NASDAQ:MRNA), sold a...

Investing.com 13 Apr 2024

Moderna (MRNA) Surges 6.2%: Is This an Indication of Further Gains?

Moderna MRNA shares ended the last trading session 6.2% higher at $111.60. The jump came on an im...

Zacks via Yahoo Finance 10 Apr 2024

What made Moderna stock pop 10% on Tuesday?

Jefferies analyst made positive remarks on MRNA-4157 today. Moderna stock is now up close to 30% ...

Invezz 9 Apr 2024

With 68% ownership, Moderna, Inc. (NASDAQ:MRNA) boasts of strong institutional backing

Key Insights Given the large stake in the stock by institutions, Moderna's stock price might be v...

Simply Wall St. via Yahoo Finance 9 Apr 2024

Moderna director Afeyan sells shares worth over $1.5 million By Investing.com

In a recent transaction, Noubar Afeyan, a director at Moderna , Inc. (NASDAQ:MRNA), sold shares o...

Investing.com 6 Apr 2024

Moderna director Afeyan sells shares worth over $1.5 million By Investing.com

In a recent transaction, Noubar Afeyan, a director at Moderna , Inc. (NASDAQ:MRNA), sold shares o...

Investing.com 5 Apr 2024

Moderna's Vaccines Day 2024: A Glimpse into the Future of Infectious Disease Prevention - Moderna...

Moderna, Inc. MRNA recently hosted its fourth annual Vaccines Day, offering a deep dive into the ...

Benzinga 5 Apr 2024

Biotech Stock Roundup: IRON, VERV Down on Study Updates, BMYs Drug News & More

Pipeline and regulatory updates continue to be in focus in the biotech sector. While nothing much...

Zacks via Yahoo Finance 5 Apr 2024

Arbutus Vs. Moderna Patent Dispute Over Covid-19 Vaccine Gets Response From Judge By Benzinga

A Delaware District Court sided with Arbutus Biopharma Corporation (NASDAQ:ABUS) and Genevant...

Investing.com 5 Apr 2024